Treatment of autologous stem cell transplant-eligible multiple myeloma patients: ten questions and answers

Abstract excerpt

Autologous stem cell transplantation is currently considered the standard of care for multiple myeloma in young patients with adequate organ function, based on the results of trials conducted in the era prior to the advent of novel agents. While these trials demonstrated the superiority of high-dose

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Cancer Treatment and Pharmacology
• Share to Multiple Myeloma Research and Treatments
• Share to Protein Degradation and Inhibitors